3rd International Congress of the Greek Local Chapter of the CRS (Controlled Release Society)




WELCOME MESSAGE

Dear Colleagues, 

It is our privilege and special pleasure to invite you to the 3rd International Congress of the Greek Local Chapter of the Controlled Release Society, on June 19th - 20th, 2017 in Athens, Greece. 
This year the program focuses on the scientific and regulatory aspects of the two main formulation categories, namely, generics and biotechnological drugs/Biosimilars. In addition, special emphasis is given to the emerging field of complex drugs. 
The list of topics quoted below gives a more detailed picture of the topics covered. We encourage the submission of oral or poster presentations from young scientists. 

In order to guarantee the quality of future research and new practical applications, a dialogue between experienced colleagues, young scientists and professional is also encouraged.

We are looking forward to welcoming you in Athens, Greece.

Panos Macheras                                                                                                                            
Professor Emeritus, Faculty of Pharmacy, University of Athens

Paris A Kosmidis 
Medical oncologist, Head Department of Medical Oncology, Hygeia Hospital Athens                                   

 

GENERAL INFORMATION 
Dates: 19-20 June, 2017 

CONGRESS VENUE 
Titania Hotel Panepistimiou 52 , 
Athens 106 78 - Greece 
Tel: +30.210-33.26.000 - Fax: +30.210-33.00.700 
web: www.titania.gr - e-mail: titania@titania.gr


CONFIRMED SPEAKERS
Henning H. Blume
George Digenis
Maria Denis
László Endrényi
Maria Gazouli
Atilla Hincal
Imre Klebovitch
Panos Macheras
Despoina Sanoudou
Vinod P. Shah
Clive Wilson

FIRST ANNOUNCEMENT
To download the 1st Announcement of the Congress, please click here.

TOPICS
GENERICS: A. Scientific aspects of drug development and research such as dissolution and permeability studies, formulation work for conventional and modified release formulations (various routes of administration), analytical work, pharmacokinetic/pharmacodynamic and bioequivalence studies; pharmacology and clinical pharmacology work. B. Regulatory issues such as biopharmaceuitc classification of drugs, biowaiver concepts, pediatric formulations, EMA and FDA guidelines, good manufacturing practice, good laboratory practice and good clinical practice.

COMPLEX DRUGS:
Scientific and regulatory aspects for polymeric micelles, glatiramoids, iron carbohydrate complexes, low molecular heparines (molecules very close to complex drygs ) will be discussed.

BIOTECHNOLOGICAL DRUGS (BIOSIMILARS): Physicochemical, immunological and regulatory aspects; clinical and non clinical work; applications in clinical practice.

FINAL PROGRAM
Please click here to download the Final Program of the Congress.

REGISTRATION

Registration Fee

Registration Categories 

   Till April 28th, 2017   

   From April 29th, 2017 & On-site 

Participants

 70€

90€ 

Industry 

 100€

120€

Students

 20€

30€

Postgraduate Students

 40€

50€

* Participants who register as “students” need to send a copy of their student card to the Congress Secretariat, in order for the registration to be confirmed. The original ID must also be presented on site at the Congress Secretariat.

Registration Fee includes:

• Attendance of the Scientific Program
• Participation to the Opening Ceremony, Welcome Reception
• Congress material
• Certificate of attendance
• Coffee Breaks

To register online please click here